Latest News

Nuheara updates on clinical development of new medical device November 25, 2021

Nuheara (ASX:NUH) says it has completed the recruitment of candidates for the clinical trial of its hearing aids being conducted by the National Acoustics Laboratory.

Biotron's BIT225 effective against COVID-19 in animal study November 25, 2021

Biotron (ASX:BIT) has announced that its lead clinical asset, BIT225, has demonstrated substantial and clinically meaningful efficacy against SARS-CoV-2 in a series of animal and cell-based studies performed at The SCRIPPS Research Institute in the US.

Nominations open for Prime Minister’s science prizes November 25, 2021

Nominations have opened for the Prime Minister’s Prizes for Science, Australia’s most prestigious awards for outstanding achievements in scientific research and research-based innovation.

Researchers find new target to combat lung disease November 25, 2021

Research led by the Centenary Institute and the University of Technology Sydney has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease.

Official reopening of biologics manufacturing facility in Adelaide November 25, 2021

BioCina acquired the facility from Pfizer and it has now been launched as a biologics contract development and manufacturing facility.

Member feedback sought on mandatory reporting of adverse events November 23, 2021

AusBiotech is seeking feedback from members that may be impacted by potential TGA regulation changes on Mandatory Reporting of Medical Device Adverse Events by Healthcare Facilities in Australia.

Study investigating new treatment for pancreatic cancer November 23, 2021

An Australian-first study is underway to determine whether using electrical charges to destroy pancreatic cancer cells can lead to improved survival rates for some patients.

CSL's new headquarters will be home to biotech incubator November 23, 2021

The incubator will be located over two floors at CSL’s new global corporate headquarters that is currently under construction in the Melbourne Biomedical Precinct.

Race Oncology announces chemotherapy heart protection data November 23, 2021

The company said this is the first time a drug has demonstrated the ability to both target the cancer and protect the heart from anthracycline damage.

Trajan acquires German-based manufacturing company November 23, 2021

Analytical science and device company Trajan (ASX:TRJ) has acquired the operations and properties of German company Axel Semrau for a total of €17 million.

PYC Therapeutics announces the successful completion of key translational milestone November 18, 2021

PYC Therapeutics (ASX:PYC) says it has completed a key translational milestone for its RNA platform by determining safe and well-tolerated doses of its co-lead drug candidate in non-human primates.

Imugene announces new study supply agreement for PD-L1 November 18, 2021

Imugene (ASX:IMU) has announced a new supply agreement with Pfizer and Merck for a trial involving their PBS-listed PD-L1 BAVENCIO (avelumab).

Most Read

New Stories

Nuheara updates on clinical development of new medical device

Biotron's BIT225 effective against COVID-19 in animal study

Nominations open for Prime Minister’s science prizes

Researchers find new target to combat lung disease

Official reopening of biologics manufacturing facility in Adelaide

Member feedback sought on mandatory reporting of adverse events

Study investigating new treatment for pancreatic cancer

Sign In